Komori
Revisions to earnings forecasts2689OLBA DVx HEALTHCARE,Inc.Trading & Wholesale

Notice Regarding the Release of Earnings and Dividend Forecasts

The company announced, for the first time, consolidated forecasts for the interim period and full year of the fiscal year ending June 2027, which had previously been undetermined. It also set the annual dividend at ¥80 per share (¥0 interim, ¥80 year-end).

Worth reading
74In focus
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending June 2027 · Second quarter (interim period) and full yearPrevious forecast published 12 August 2026
Net Sales—→—million
—
Operating profit—→—million
—
Ordinary income—→—million
—
Profit attributable to owners of the parent—→—million
—
Net income per share—→—Yen
—

The bar length represents the relative magnitude of change, based on the item that changed the most in this document.

Reason for the revision

The completion of the review of business performance accompanying the business integration with DVx effective 1 September 2026 made DVx's forecast figures available and established the prerequisites for preparing consolidated estimates. The forecasts also incorporate integration-related costs and the straight-line amortization over 10 years of provisionally estimated goodwill.

Previous-period resultsConsolidated results for the second quarter (interim period) of the fiscal year ended June 2026: net sales of ¥62,444 million, operating profit of ¥673 million, ordinary profit of ¥675 million, interim net income attributable to owners of the parent of ¥450 million, and interim net income per share of ¥76.02. Consolidated results for the full fiscal year ended June 2026: net sales of ¥126,595 million, operating profit of ¥1,679 million, ordinary profit of ¥1,664 million, net income attributable to owners of the parent of ¥1,112 million, and net income per share of ¥187.67.
Dividend forecast revisionThe previous forecast was undetermined. The current forecast is ¥0.00 at the interim period-end, ¥80.00 at the year-end, and ¥80.00 for the full year. The year-end dividend forecast is the same as in the previous fiscal year.
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net SalesNot disclosed → Interim period: 80,285; full year: 178,885
Operating profitNot disclosed → Interim period: 669; full year: 1,986
Ordinary incomeNot disclosed → Interim period: 646; full year: 1,950
Profit attributable to owners of the parentNot disclosed → Interim net income attributable to owners of the parent: 355; full-year net income attributable to owners of the parent: 1,172
Net income per shareNot disclosed → Interim period: 43.09; full year: 130.30
Fiscal Period CoveredFiscal year ending June 2027
Period CoveredSecond quarter (interim period) and full year
Publication date of previous forecast12 August 2026
Previous-period resultsConsolidated results for the second quarter (interim period) of the fiscal year ended June 2026: net sales of ¥62,444 million, operating profit of ¥673 million, ordinary profit of ¥675 million, interim net income attributable to owners of the parent of ¥450 million, and interim net income per share of ¥76.02. Consolidated results for the full fiscal year ended June 2026: net sales of ¥126,595 million, operating profit of ¥1,679 million, ordinary profit of ¥1,664 million, net income attributable to owners of the parent of ¥1,112 million, and net income per share of ¥187.67.
Reason for the revisionThe completion of the review of business performance accompanying the business integration with DVx effective 1 September 2026 made DVx's forecast figures available and established the prerequisites for preparing consolidated estimates. The forecasts also incorporate integration-related costs and the straight-line amortization over 10 years of provisionally estimated goodwill.
Dividend forecast revisionThe previous forecast was undetermined. The current forecast is ¥0.00 at the interim period-end, ¥80.00 at the year-end, and ¥80.00 for the full year. The year-end dividend forecast is the same as in the previous fiscal year.
Consolidated / non-consolidatedConsolidated
Items this document does not state (1)
Details and amount of extraordinary loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Following the business integration with DVx, the forecast figures became available and the prerequisites for preparing consolidated estimates were in place. The forecasts were announced based on the information currently available and reasonable assumptions, incorporating integration-related costs and goodwill amortization.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Release of Earnings and Dividend Forecasts | OLBA DVx HEALTHCARE,Inc. (2689) timely disclosure | Komori